ArticleOpen forum infectious diseases2026

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil.

Erica J Stohs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.